Week in Review: June 16–20

Early Neanderthal evolution; developing antivirals to combat polio; the mouth and skin microbiomes; insect-inspired, flight-stabilizing sensors

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

JAVIER TRUEBA/MADRID SCIENTIFIC FILMSSeventeen skulls excavated from Spain’s Sima de los Huesos and thought to be around 430,000 years old are the oldest specimens with Neanderthal features uncovered to date. Researchers from Complutense University of Madrid reported on their analysis of these skulls in Science this week (June 19). The team found evidence suggesting that these ancient individuals were not fully Neanderthal, yet not quite Homo heidelbergensis, either.

“Until recently, most [scientists] supported [the idea] that Neanderthals emerged, at most, 250,000 years ago. The discovery at Sima demonstrates that there is a much deeper history of the Neanderthals than we previously thought, to at least 430,000 years ago,” said Jean-Jacques Hublin from the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany, who was not involved in the work. “[These new specimens] are clearly not like the late Neanderthals, but ancestral forms of Neanderthals.”

FLICKR, JULIEN HARNEISThere are two antiviral drugs being tested to treat polio, and researchers battling the spread of the disease where vaccination is incomplete are banking on their success. One of the drugs, pocapavir, has shown promise in early clinical trials. But scientists face the lingering challenge of containing poliovirus excretion by immunocompromised persons who have been vaccinated.

“There can be no true eradication of polio with the continued presence of prolonged poliovirus excreters,” Mark McKinlay, head of the Polio Antivirals Initiative within The Task Force for Global Health, told The Scientist in an e-mail.

FLICKR, NATIONAL MUSEUM OF HEALTH AND MEDICINEThe Scientist continued its deep dive into the human microbiomes outside of the gastrointestinal tract this week, with a look at the microbial communities that inhabit the mouth and skin.

“Particularly for skin, we are only just now understanding who is there,” said Heidi Kong from the National Cancer Institute. “The next, much more complex part of this is what are they doing there and how are we ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies